
  
    
      
        Introduction_NNP
        Arthritic_NNP diseases_NNS are_VBP characterized_VBN by_IN a_DT progressive_JJ
        loss_NN of_IN extracellular_NN matrix_NN (_( ECM_NNP )_) ,_, which_WDT may_MD ultimately_RB
        lead_VB to_TO frank_JJ tissue_NN loss_NN and_CC gross_JJ joint_JJ damage_NN ._. The_DT
        conditions_NNS under_IN which_WDT chondrocytes_NNS can_MD be_VB induced_VBN to_TO
        replenish_VB or_CC repair_VB a_DT depleted_VBN matrix_NN (_( and_CC thereby_RB prevent_VB
        or_CC slow_VB the_DT disease_NN process_NN )_) remain_VB unclear_JJ ._. If_IN these_DT
        conditions_NNS were_VBD known_VBN ,_, then_RB in_IN principal_JJ one_PRP could_MD design_VB a_DT
        therapeutic_JJ strategy_NN that_WDT takes_VBZ into_IN account_NN the_DT capacity_NN
        (_( or_CC absence_NN thereof_RB )_) for_IN chondrocytes_NNS to_TO repair_VB their_PRP$
        matrix_NN naturally_RB ._.
        A_DT number_NN of_IN model_NN systems_NNS have_VBP provided_VBN some_DT insights_NNS ._.
        For_IN instance_NN ,_, IL-_NNP 1_CD -_: degraded_JJ cartilage_NN tissues_NNS and_CC cell_NN
        suspensions_NNS are_VBP frequently_RB employed_VBN as_IN model_NN systems_NNS to_TO
        study_VB cartilage_NN metabolism_NN under_IN osteoarthritis-like_JJ
        conditions_NNS [_NN 1_CD 2_CD 3_CD 4_CD ]_NN and_CC to_TO assess_VB the_DT efficacy_NN of_IN
        various_JJ drug_NN therapies_NNS [_NN 5_CD 6_CD 7_CD 8_CD 9_CD ]_NN ._. IL-_NNP 1_CD signals_NNS cells_NNS
        via_IN cell_NN surface_NN receptors_NNS to_TO upregulate_NN proteases_NNS ,_, matrix_NN
        metalloproteinases_NNS and_CC aggrecanase_NN ,_, while_IN downregulating_VBG
        matrix_NN metalloproteinase_NN inhibition_NN and_CC proteoglycan_NN
        synthesis_NN [_NN 10_CD 11_CD ]_NN ._. The_DT ultimate_JJ effect_NN of_IN these_DT
        metabolic_JJ changes_NNS include_VBP damage_NN to_TO the_DT ECM_NNP ,_, loss_NN of_IN ECM_NNP
        components_NNS (_( especially_RB proteoglycan_NN )_) ,_, and_CC alteration_NN of_IN the_DT
        normal_JJ balance_NN of_IN catabolic_JJ and_CC anabolic_JJ processes_NNS that_WDT
        regulate_VB cartilage_NN ECM_NNP composition_NN ._.
        With_IN regard_NN to_TO the_DT repair_NN phase_NN ,_, following_VBG IL-_NNP 1_CD -_: induced_VBN
        cartilage_NN damage_NN ,_, relatively_RB little_JJ is_VBZ known_VBN ,_, but_CC partial_JJ
        to_TO complete_VB recovery_NN appears_VBZ possible_JJ [_NN 1_CD 3_CD ]_NN ._. In_IN studies_NNS
        of_IN repair_NN ,_, investigators_NNS focused_VBN on_IN glycosaminoglycan_NN (_( GAG_NNP )_)
        -_: an_DT important_JJ and_CC abundant_JJ cartilage_NN macromolecule_NN -_: and_CC
        used_VBN histologic_JJ ,_, biochemical_JJ ,_, and_CC /_NN or_CC radiolabel_NN
        incorporation_NN methods_NNS to_TO measure_VB GAG_NNP concentration_NN (_( [_NN GAG_NNP ]_NN )_)
        and_CC /_NN or_CC GAG_NNP synthesis_NN rates_NNS at_IN selected_VBN time_NN points_NNS ._.
        Although_IN these_DT data_NNS suggest_VBP that_DT repair_NN might_MD be_VB possible_JJ ,_,
        our_PRP$ understanding_NN is_VBZ limited_VBN because_IN of_IN the_DT uncertainty_NN in_IN
        the_DT temporal_JJ changes_NNS in_IN matrix_NN composition_NN for_IN a_DT given_VBN
        sample_NN ._. This_DT uncertainty_NN is_VBZ a_DT direct_JJ consequence_NN of_IN the_DT
        inherently_RB destructive_JJ nature_NN of_IN histologic_JJ and_CC biochemical_JJ
        methods_NNS ;_: these_DT techniques_NNS therefore_RB do_VBP not_RB permit_VB
        monitoring_NN of_IN the_DT spatial_NN and_CC temporal_JJ evolution_NN of_IN matrix_NN
        macromolecules_NNS within_IN individual_JJ samples_NNS /_NN animals_NNS ._. Having_VBG to_TO
        infer_NN temporal_JJ spatial_NN information_NN from_IN a_DT cross-section_NN of_IN
        samples_NNS confounds_NNS efforts_NNS to_TO conduct_VB a_DT detailed_VBN analysis_NN of_IN
        responses_NNS in_IN these_DT model_NN systems_NNS ._.
        The_DT delayed_VBN Gadolinium-_NNP Enhanced_NNP Magnetic_JJ Resonance_NNP
        Imaging_NNP of_IN Cartilage_NNP (_( dGEMRIC_NN )_) method_NN overcomes_VBZ these_DT
        problems_NNS in_IN that_IN it_PRP is_VBZ nondestructive_JJ and_CC can_MD be_VB used_VBN to_TO
        assess_VB quantitatively_RB the_DT spatial_NN distribution_NN of_IN cartilage_NN
        [_NN GAG_NNP ]_NN [_NN 12_CD 13_CD ]_NN ._. We_PRP and_CC others_NNS previously_RB reported_VBD on_IN the_DT
        use_NN of_IN dGEMRIC_NN to_TO monitor_VB GAG_NNP regeneration_NN in_IN living_VBG
        cartilage_NN tissue_NN over_IN time_NN in_IN trypsin-depleted_JJ bovine_JJ
        cartilage_NN [_NN 14_CD ]_NN and_CC in_IN cell-laden_JJ polymer_NN matrices_NNS (_( tissue_NN
        engineered_VBN cartilage_NN )_) [_NN 15_CD ]_NN ._. Those_DT studies_NNS clearly_RB
        demonstrated_VBN that_DT dGEMRIC_NN is_VBZ feasible_JJ for_IN long-term_JJ [_NN GAG_NNP ]_NN
        monitoring_NN ,_, and_CC that_IN its_PRP$ sensitivity_NN is_VBZ sufficient_JJ to_TO
        permit_VB observation_NN of_IN the_DT spatiotemporal_NN evolution_NN of_IN
        [_NN GAG_NNP ]_NN ._. Each_DT of_IN those_DT studies_NNS began_VBD with_IN a_DT homogeneously_RB
        proteoglycan-deficient_JJ matrix_NN ,_, in_IN which_WDT GAG_NNP was_VBD replenished_VBN
        over_IN a_DT 5_CD -_: to_TO 8_CD -_: week_NN period_NN to_TO levels_NNS considered_VBN to_TO be_VB
        within_IN the_DT normal_JJ range_NN ._.
        In_IN young_JJ bovine_JJ articular_NN cartilage_NN (_( a_DT tissue_NN that_IN many_JJ
        investigators_NNS have_VBP used_VBN to_TO investigate_VB the_DT impact_NN of_IN
        physical_JJ and_CC biochemical_JJ factors_NNS on_IN ECM_NNP metabolism_NN [_NN 14_CD 16_CD
        17_CD 18_CD 19_CD 20_CD 21_CD ]_NN )_) ,_, IL-_NNP 1_CD induces_VBZ a_DT characteristic_NN spatially_RB
        heterogeneous_JJ depletion_NN of_IN GAG_NNP ._. This_DT young_JJ tissue_NN still_RB
        contains_VBZ blood_NN vessels_NNS ,_, and_CC it_PRP is_VBZ in_IN the_DT perivascular_NN
        regions_NNS that_IN IL-_NNP 1_CD -_: induced_VBN GAG_NNP depletion_NN is_VBZ most_RBS severe_JJ ._. We_PRP
        know_VBP from_IN studies_NNS investigating_VBG the_DT recovery_NN of_IN
        trypsin-induced_JJ homogeneous_JJ GAG_NNP depletion_NN in_IN young_JJ bovine_JJ
        cartilage_NN that_IN the_DT inherent_JJ ability_NN of_IN chondrocytes_NNS to_TO
        replenish_VB the_DT matrix_NN is_VBZ relatively_RB uniform_NN [_NN 14_CD ]_NN ._. In_IN the_DT
        present_JJ study_NN ,_, we_PRP take_VBP advantage_NN of_IN the_DT characteristic_JJ
        spatial_NN heterogeneity_NN of_IN IL-_NNP 1_CD -_: induced_VBN GAG_NNP depletion_NN to_TO
        study_VB the_DT relative_JJ replenishment_NN rates_NNS between_IN regions_NNS of_IN
        varying_VBG severity_NN of_IN GAG_NNP depletion_NN ._. Accordingly_RB ,_, our_PRP$ goal_NN
        was_VBD to_TO use_VB dGEMRIC_NN to_TO determine_VB whether_IN bovine_JJ cartilage_NN
        explants_NNS briefly_NN exposed_VBN to_TO IL-_NNP 1_CD would_MD recover_VB GAG_NNP at_IN a_DT
        uniform_NN rate_NN ,_, or_CC at_IN a_DT rate_NN that_WDT depended_VBD on_IN the_DT degree_NN of_IN
        IL-_NNP 1_CD -_: induced_VBN GAG_NNP depletion_NN ._. Specifically_RB ,_, we_PRP sought_VBD to_TO
        examine_VB recovery_NN after_IN relatively_RB mild_JJ and_CC modest_JJ
        degradation_NN -_: conditions_NNS that_WDT did_VBD not_RB induce_VB a_DT complete_JJ
        loss_NN of_IN tissue_NN GAG_NNP ._.
      
      
        Method_NNP
        
          Culture_NNP and_CC degradation_NN protocols_NNS
          Cartilage-bone_NNP cores_NNS of_IN 5_CD mm_NN or_CC 7_CD mm_NN in_IN diameter_NN were_VBD
          harvested_VBN from_IN young_JJ bovine_JJ femoropatellar_NN groove_NN
          articular_NN cartilage_NN within_IN 24_CD hours_NNS of_IN slaughter_NN ._. After_IN
          removing_VBG the_DT articular_NN surface_NN ,_, three_CD or_CC four_CD 1_CD -_: mm-thick_JJ
          discs_NNS were_VBD sliced_JJ parallel_NN to_TO the_DT articular_NN surface_NN ._. A_DT
          flat_JJ edge_NN was_VBD made_VBN on_IN some_DT of_IN the_DT discs_NNS to_TO ease_VB
          orientation_NN and_CC registration_NN during_IN imaging_NN and_CC analysis_NN ._.
          The_DT discs_NNS were_VBD weighed_VBN ,_, and_CC then_RB immediately_RB placed_VBN in_IN
          2_CD ml_NN sterile_JJ culture_NN media_NNS in_IN 24_CD -_: well_RB culture_NN plates_NNS ._. All_DT
          explants_NNS were_VBD incubated_JJ at_IN 37_CD Â°_NN C_NNP throughout_IN the_DT study_NN ._.
          Culture_NNP medium_NN was_VBD prepared_VBN with_IN low-glucose_JJ
          Dulbecco_NNP 's_POS modified_VBN Eagle_NNP medium_NN with_IN 10_CD mmol_NN /_NN l_NN HEPES_NNP
          (_( GIBCO_NNP BRL_NNP ,_, Grand_NNP Island_NNP ,_, NY_NNP ,_, USA_NNP )_) ,_, 0_CD ._. 1_CD mmol_NN /_NN l_NN
          nonessential_JJ amino_JJ acids_NNS (_( Sigma_NNP Chemical_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP ,_,
          USA_NNP )_) ,_, 0_CD ._. 4_CD mmol_NN /_NN l_NN L-_NNP proline_NN (_( Sigma_NNP Chemical_NNP )_) ,_, and_CC 1_CD mmol_NN /_NN l_NN
          gadolinium-_NN DTPA_NNP (_( Magnevist_NNP ,_, Berlex_NNP Imaging_NNP ,_, Wayne_NNP ,_, NJ_NNP ,_,
          USA_NNP )_) ._. Supplements_NNP including_VBG :_: 1_CD %_NN fetal_JJ calf_NN serum_NN (_( GIBCO_NNP
          BRL_NNP ,_, Grand_NNP Island_NNP ,_, NY_NNP )_) ,_, 1_CD %_NN l-glutamine_JJ (_( Sigma_NNP Chemical_NNP )_) ,_,
          1_CD %_NN ascorbic_JJ acid_NN (_( Sigma_NNP Chemical_NNP )_) and_CC 1_CD %_NN penicillin_NN and_CC
          streptomycin_NN (_( Sigma_NNP Chemical_NNP )_) were_VBD added_VBN immediately_RB
          prior_RB to_TO use_VB ._. Media_NNP was_VBD was_VBD collected_VBN daily_JJ and_CC analyzed_VBD
          for_IN GAG_NNP release_NN by_IN the_DT dimethylmethylene_NN blue_JJ (_( DMMB_NNP )_)
          assay_NN using_VBG purified_JJ shark_NN chondroitin_NN sulfate_NN (_( Sigma_NNP
          Chemical_NNP )_) as_IN the_DT reference_NN standard_JJ ._.
          All_DT samples_NNS were_VBD cultured_JJ in_IN basal_NN media_NNS for_IN at_IN least_JJS
          3_CD days_NNS after_IN harvest_NN ._. To_TO create_VB samples_NNS that_WDT have_VBP
          heterogeneously-degraded_JJ ECM_NNP ,_, samples_NNS were_VBD exposed_VBN to_TO
          IL-_NNP 1_CD Î²_NN (_( Cistron_NNP Biotechnology_NNP ,_, Pine_NNP Brooks_NNP ,_, NJ_NNP ,_, USA_NNP )_) ,_,
          which_WDT was_VBD added_VBN each_DT day_NN to_TO the_DT culture_NN medium_NN ._. Two_CD
          series_NN of_IN experiments_NNS were_VBD conducted_VBN ,_, each_DT with_IN its_PRP$ own_JJ
          set_NN of_IN controls_NNS ._. In_IN the_DT first_JJ series_NN ,_, samples_NNS were_VBD
          exposed_VBN to_TO 10_CD ng_NN /_NN ml_NN IL-_NNP 1_CD for_IN 3_CD and_CC 6_CD days_NNS (_( incurring_VBG
          '_POS mild_JJ '_POS degradation_NN ;_: 
          n_NN =_SYM 4_LS )_) ._. The_DT addition_NN of_IN IL-_NNP 1_CD to_TO the_DT
          media_NNS began_VBD at_IN days_NNS 6_CD and_CC 3_CD ,_, respectively_RB ,_, after_IN harvest_NN ,_,
          such_JJ that_IN all_DT samples_NNS began_VBD the_NNP '_POS recovery_NN phase_NN '_'' on_IN day_NN 9_CD
          after_IN harvest_NN ._. Control_NN samples_NNS were_VBD cultured_JJ in_IN basal_NN
          media_NNS for_IN the_DT entire_JJ experiment_NN ._. In_IN the_DT second_JJ series_NN ,_,
          samples_NNS were_VBD exposed_VBN to_TO 20_CD ng_NN /_NN ml_NN IL-_NNP 1_CD (_( 
          n_NN =_SYM 10_CD )_) for_IN 6_CD and_CC 9_CD days_NNS and_CC
          incurred_VBN '_POS moderate_JJ '_POS degradation_NN ._. In_IN this_DT group_NN the_DT
          addition_NN of_IN IL-_NNP 1_CD addition_NN to_TO the_DT media_NNS for_IN all_DT samples_NNS

          started_VBD at_IN 3_CD days_NNS after_IN harvest_NN ,_, and_CC therefore_RB samples_NNS
          began_VBD the_DT recovery_NN phase_NN at_IN day_NN 9_CD or_CC 12_CD after_IN harvest_NN ._.
          Again_RB ,_, control_NN samples_NNS were_VBD cultured_JJ in_IN basal_NN media_NNS for_IN
          the_DT entire_JJ experiment_NN ._. Control_NN samples_NNS are_VBP referred_VBN to_TO as_IN
          '_POS mild_JJ controls_NNS '_POS or_CC '_POS moderate_JJ controls_NNS '_POS ,_, according_VBG to_TO the_DT
          IL-_NNP 1_CD series_NN with_IN which_WDT they_PRP were_VBD cultured_JJ (_( 
          n_NN =_SYM 2_CD and_CC 2_LS )_) ._.
          Following_VBG IL-_NNP 1_CD exposure_NN ,_, the_DT samples_NNS were_VBD transferred_VBN
          to_TO sterile_JJ flat-bottomed_JJ 10_CD mm_NN nuclear_JJ magnetic_JJ resonance_NN
          (_( NMR_NNP )_) tubes_NNS (_( Wilbur_NNP Scientific_NNP ,_, Boston_NNP ,_, MA_NNP ,_, USA_NNP )_) that_WDT
          were_VBD custom_NN cut_NN to_TO a_DT length_NN of_IN 5_CD cm_NN ,_, where_WRB they_PRP were_VBD
          cultured_JJ in_IN basal_NN media_NNS for_IN the_DT duration_NN of_IN the_DT recovery_NN
          experiment_NN ._.
          In_IN summary_NN ,_, the_DT experiment_NN comprised_VBN three_CD periods_NNS :_: an_DT
          initial_JJ period_NN (_( before_IN any_DT exposure_NN to_TO IL-_NNP 1_LS )_) ,_, an_DT exposure_NN
          period_NN (_( during_IN which_WDT tissue_NN was_VBD exposed_VBN to_TO IL-_NNP 1_CD in_IN
          preparation_NN for_IN the_DT recovery_NN phase_NN )_) ,_, followed_VBN by_IN a_DT
          recovery_NN period_NN (_( during_IN which_WDT there_EX was_VBD no_DT IL-_NNP 1_CD
          present_JJ )_) ._.
        
        
          Imaging_NNP protocols_NNS
          For_IN imaging_NN ,_, the_DT shortened_VBN NMR_NNP /_NN culture_NN tubes_NNS were_VBD
          joined_VBN to_TO full-length_JJ NMR_NNP tubes_NNS via_IN a_DT sterilized_VBN rubber_NN
          stopper_NN inserted_VBN into_IN the_DT open_JJ ends_NNS of_IN both_DT tubes_NNS ._.
          All_DT images_NNS were_VBD acquired_VBN on_IN a_DT Bruker_NNP 8_CD ._. 45_CD T_NN magnetic_JJ
          resonance_NN microimaging_VBG system_NN (_( Bruker_NNP Instruments_NNP ,_,
          Billerica_NNP ,_, MA_NNP ,_, USA_NNP )_) with_IN a_DT standard_JJ 10_CD mm_NN radiofrequency_NN
          coil_NN ._. T_NN 1_CD -_: weighted_JJ images_NNS in_IN the_DT axial_NN orientation_NN with_IN
          respect_NN to_TO explant_NN cylindrical_JJ geometry_NN were_VBD measured_VBN
          weekly_JJ post-_NN IL-_NNP 1_CD exposure_NN with_IN either_DT an_DT inversion_NN
          recovery_NN sequence_NN (_( '_POS mild_JJ '_POS series_NN )_) or_CC a_DT saturation_NN
          recovery_NN sequence_NN (_( '_POS moderate_JJ '_POS series_NN )_) ._. The_DT saturation_NN
          recovery_NN protocol_NN consisted_VBD of_IN 10_CD T_NN 1_CD -_: weighted_JJ images_NNS
          measured_VBN with_IN time-to-repeat_JJ times_NNS of_IN 25_CD ,_, 75_CD ,_, 125_CD ,_, 175_CD ,_,
          275_CD ,_, 375_CD ,_, 475_CD ,_, 600_CD ,_, 900_CD ,_, and_CC 1800_CD ms_NNS ._. For_IN inversion_NN
          recovery_NN measurements_NNS ,_, images_NNS were_VBD acquired_VBN with_IN nine_CD
          inversion_NN delays_NNS of_IN 16_CD ._. 7_CD ,_, 33_CD ._. 3_LS ,_, 50_CD ,_, 66_CD ._. 7_CD ,_, 100_CD ,_, 150_CD ,_, 250_CD ,_,
          400_CD ,_, and_CC 600_CD ms_NNS ._. Both_DT pulse_NN sequences_NNS used_VBD a_DT time-to-echo_JJ
          of_IN 8_CD ._. 5_CD ms_NNS ,_, section_NN thicknesses_NNS of_IN 0_CD ._. 5_CD mm_NN ,_, in-plane_JJ
          resolutions_NNS of_IN 100_CD Î¼m_NN ,_, and_CC two_CD averages_NNS ,_, for_IN a_DT total_JJ
          imaging_NN time_NN of_IN less_JJR than_IN 1_CD hour_NN per_IN sample_NN ._.
          Analysis_NNP of_IN GAG_NNP release_NN throughout_IN these_DT experiments_NNS
          suggested_VBD that_IN ,_, within_IN the_DT range_NN of_IN sensitivity_NN provided_VBN
          by_IN our_PRP$ dimethylmethylene_NN blue_JJ assay_NN ,_, GAG_NNP release_NN patterns_NNS
          were_VBD unaffected_JJ by_IN removal_NN from_IN incubation_NN at_IN 37_CD Â°_NN C_NNP to_TO
          room_NN temperature_NN for_IN 3_CD -_: 6_CD hours_NNS of_IN imaging_NN each_DT week_NN
          (_( because_IN all_PDT the_DT plugs_NNS were_VBD out_IN of_IN the_DT incubator_NN for_IN the_DT
          imaging_NN session_NN )_) ._.
          Tissue_NNP T_NN 1_CD s_VBZ without_IN contrast_NN agent_NN were_VBD determined_VBN
          spectroscopically_RB using_VBG an_DT inversion_NN delay_NN pulse_NN sequence_NN
          with_IN 12_CD delays_NNS ranging_VBG from_IN 0_CD ._. 2_CD to_TO 10_CD s_VBZ and_CC a_DT 10_CD mm_NN
          broadband_NN radiofrequency_NN probe_NN ._. At_IN the_DT conclusion_NN of_IN each_DT
          experimental_JJ series_NN ,_, two_CD samples_NNS (_( one_CD control_NN and_CC one_CD
          treated_VBN )_) were_VBD equilibrated_JJ in_IN gadolinium-free_JJ medium_NN ,_,
          then_RB extracted_VBN from_IN media_NNS and_CC blotted_JJ dry_JJ ,_, and_CC placed_VBD in_IN
          an_DT NMR_NNP tube_NN ._. As_IN had_VBD previously_RB been_VBN observed_VBN ,_, we_PRP found_VBD
          very_RB little_JJ difference_NN in_IN T_NN 1_CD between_IN samples_NNS of_IN the_DT same_JJ
          series_NN (_( <_NN 5_CD %_NN )_) or_CC across_IN series_NN (_( <_NN 10_CD %_NN )_) [_NN 12_CD ]_NN ._.
          Therefore_RB ,_, the_DT T_NN 1_CD times_NNS in_IN the_DT absence_NN of_IN contrast_NN agent_NN
          of_IN samples_NNS from_IN the_DT same_JJ series_NN were_VBD averaged_VBN and_CC these_DT
          averages_NNS used_VBN as_IN the_DT reference_NN tissue_NN T_NN 1_CD for_IN all_DT other_JJ
          samples_NNS within_IN the_DT same_JJ experiment_NN series_NN ._.
        
        
          Image_NN processing_NN
          MATLAB_NNP (_( The_DT Math_NNP Works_NNP ,_, Natick_NNP ,_, MA_NNP ,_, USA_NNP )_) was_VBD used_VBN to_TO
          create_VB a_DT T_NN 1_CD map_NN by_IN curve-fitting_JJ each_DT T_NN 1_CD -_: weighted_JJ image_NN
          series_NN on_IN a_DT voxel-by-voxel_JJ basis_NN ._. T_NN 1_CD maps_NNS were_VBD then_RB
          processed_VBN into_IN GAG_NNP maps_NNS with_IN MATLAB_NNP using_VBG equations_NNS
          derived_VBN from_IN a_DT modified_VBN ideal_JJ Donnan_NNP theory_NN ._. This_DT dGEMRIC_NN
          method_NN of_IN relating_VBG measured_VBN T_NN 1_CD and_CC cartilage_NN [_NN GAG_NNP ]_NN was_VBD
          previously_RB validated_JJ and_CC reported_VBD [_NN 12_CD 13_CD 22_CD ]_NN ._.
          The_DT mean_JJ [_NN GAG_NNP ]_NN for_IN a_DT sample_NN at_IN a_DT given_VBN time_NN point_NN was_VBD
          computed_JJ as_IN the_DT mean_JJ [_NN GAG_NNP ]_NN calculated_VBN across_IN all_DT
          cartilage-containing_JJ pixels_NNS of_IN the_DT image_NN ._. The_DT rate_NN of_IN
          [_NN GAG_NNP ]_NN accumulation_NN (_( i_NNP ._. e_SYM ._. the_DT tissue_NN 's_POS recovery_NN rate_NN )_) was_VBD
          calculated_VBN as_IN the_DT difference_NN in_IN the_DT mean_JJ [_NN GAG_NNP ]_NN values_NNS at_IN
          specified_VBN time_NN points_NNS divided_VBN by_IN the_DT elapsed_VBN time_NN ._.
          As_IN expected_VBN ,_, qualitative_JJ assessment_NN of_IN images_NNS from_IN
          samples_NNS exposed_VBN to_TO IL-_NNP 1_CD exhibited_VBN the_DT characteristic_JJ
          heterogeneity_NN in_IN degree_NN of_IN GAG_NNP depletion_NN ._. In_IN order_NN to_TO
          quantitate_NN objectively_RB the_DT time_NN course_NN of_IN GAG_NNP recovery_NN
          relative_JJ to_TO the_DT degree_NN of_IN GAG_NNP depletion_NN ,_, GAG_NNP maps_NNS were_VBD
          registered_VBN using_VBG Adobe_NNP Photoshop_NNP (_( Adobe_NNP Systems_NNPS ,_, Inc_NNP ,_, San_NNP
          Jose_NNP ,_, CA_NNP ,_, USA_NNP )_) in_IN order_NN to_TO allow_VB chosen_VBN regions_NNS of_IN
          interest_NN to_TO be_VB automatically_RB analyzed_VBN across_IN multiple_JJ
          images_NNS from_IN successive_JJ imaging_NN sessions_NNS ._. Registered_NNP
          images_NNS were_VBD segmented_JJ so_IN that_IN tissue_NN regions_NNS of_IN
          relatively_RB high_JJ ,_, medium_NN ,_, or_CC low_JJ [_NN GAG_NNP ]_NN were_VBD identified_VBN in_IN
          images_NNS taken_VBN after_IN 3_CD weeks_NNS of_IN recovery_NN ._. The_DT [_NN GAG_NNP ]_NN and_CC
          location_NN of_IN these_DT pixels_NNS were_VBD tracked_VBN in_IN time_NN ._. High_NNP ,_,
          medium_NN ,_, and_CC low_JJ [_NN GAG_NNP ]_NN regions_NNS of_IN the_DT 3_CD -_: week_NN images_NNS were_VBD
          discerned_JJ according_VBG to_TO the_DT following_JJ definitions_NNS :_:
          Pixel_NNP assigned_VBN to_TO '_POS high_JJ '_POS GAG_NNP region_NN if_IN :_:
          [_NN GAG_NNP ]_NN 
          pixel_NN >_NN (_( mean_VB [_NN GAG_NNP ]_NN 
          all_DT pixels_NNS +_NN 0_CD ._. 5_CD Ã_NN SD_NNP 
          all_DT pixels_NNS )_)
          Pixel_NNP assigned_VBN to_TO '_POS low_JJ '_POS GAG_NNP region_NN if_IN :_:
          [_NN GAG_NNP ]_NN 
          pixel_NN <_NN (_( mean_VB [_NN GAG_NNP ]_NN 
          all_DT pixels_NNS -_: 0_CD ._. 5_CD Ã_NN SD_NNP 
          all_DT pixels_NNS )_)
          Pixel_NNP assigned_VBN to_TO '_POS medium_NN '_'' GAG_NNP region_NN if_IN not_RB assigned_VBN
          to_TO high_JJ or_CC low_JJ region_NN
        
        
          Statistical_NNP analysis_NN
          Magnetic_JJ resonance_NN imaging_NN derived_VBD group_NN mean_NN [_NN GAG_NNP ]_NN
          changes_NNS were_VBD assessed_VBN using_VBG repeated-measures_JJ oneway_NN
          analysis_NN of_IN variance_NN with_IN a_DT compound_NN symmetry_NN variance_NN
          structure_NN using_VBG SAS_NNP (_( SAS_NNP Institute_NNP Inc_NNP ._. ,_, Cary_NNP ,_, NC_NNP ,_, USA_NNP )_)
          to_TO test_VB the_DT hypothesis_NNS that_WDT mean_VBP [_NN GAG_NNP ]_NN in_IN a_DT given_VBN sample_NN
          or_CC regions_NNS of_IN a_DT given_VBN sample_NN did_VBD not_RB change_VB with_IN time_NN ._.
          This_DT technique_NN analyzed_VBD the_DT significance_NN of_IN time_NN as_IN an_DT
          effect_NN on_IN weekly_JJ [_NN GAG_NNP ]_NN measurements_NNS (_( or_CC weekly_JJ changes_NNS in_IN
          [_NN GAG_NNP ]_NN )_) taken_VBN from_IN the_DT same_JJ samples_NNS (_( or_CC same_JJ region_NN of_IN a_DT
          sample_NN )_) each_DT week_NN ._. Paired_NNP two-sample_JJ Student_NNP 's_POS 
          t_NN -_: tests_NNS (_( Microsoft_NNP Excel_NNP )_) were_VBD
          used_VBN to_TO determine_VB the_DT degree_NN of_IN [_NN GAG_NNP ]_NN recovery_NN observed_VBD
          with_IN respect_NN to_TO initial_JJ [_NN GAG_NNP ]_NN ,_, before_IN exposure_NN to_TO
          IL-_NNP 1_CD ._.
        
      
      
        Results_NNS
        
          Glycosaminoglycan_NNP release_NN into_IN media_NNS
          The_DT release_NN of_IN GAG_NNP into_IN the_DT media_NNS was_VBD measured_VBN daily_JJ
          as_IN a_DT surrogate_NN for_IN monitoring_VBG the_DT effect_NN of_IN IL-_NNP 1_CD exposure_NN
          and_CC of_IN ECM_NNP stability_NN following_VBG IL-_NNP 1_CD withdrawal_NN ._. Control_NN
          samples_NNS from_IN each_DT series_NN had_VBD a_DT small_JJ rate_NN of_IN release_NN
          throughout_IN (_( 0_CD ._. 4_LS Â±_NN 0_CD ._. 2_CD Î¼g_NN /_NN mg_NN initial_JJ wet-weight_JJ /_NN day_NN )_) ,_,
          except_IN for_IN a_DT slightly_RB higher_JJR release_NN rate_NN (_( 0_CD ._. 7_CD Â±_NN 0_CD ._. 2_LS Î¼g_NN /_NN mg_NN
          initial_JJ wet-weight_JJ /_NN day_NN )_) during_IN the_DT first_JJ 2_CD -_: 3_CD days_NNS after_IN
          harvest_NN ._. Assuming_VBG an_DT initial_JJ [_NN GAG_NNP ]_NN of_IN approximately_RB 5_CD %_NN of_IN
          wet-weight_JJ ,_, this_DT steady-state_JJ release_NN rate_NN corresponds_NNS to_TO
          a_DT loss_NN of_IN about_IN 0_CD ._. 6_CD -_: 1_CD %_NN /_NN day_NN ._.
          As_IN expected_VBN ,_, during_IN the_DT IL-_NNP 1_CD exposure_NN period_NN the_DT
          exposed_VBN samples_NNS lost_VBD significantly_RB more_JJR GAG_NNP than_IN did_VBD
          controls_NNS ,_, in_IN accordance_NN with_IN the_DT severity_NN of_IN the_DT IL-_NNP 1_CD
          exposure_NN ._. Those_DT in_IN the_NNP '_POS mild_JJ '_POS and_CC '_POS moderate_JJ '_POS groups_NNS lost_VBD
          148_CD Â±_NN 49_CD Î¼g_NN and_CC 433_CD Â±_NN 98_CD Î¼g_NN GAG_NNP ,_, respectively_RB ,_, as_IN compared_VBN with_IN
          the_DT 81_CD Â±_NN 5_CD Î¼g_NN and_CC 103_CD Â±_NN 58_CD Î¼g_NN lost_VBD during_IN the_DT same_JJ period_NN by_IN
          the_DT control_NN samples_NNS ._. The_DT GAG_NNP release_NN rates_NNS never_RB dropped_VBD
          to_TO negligible_JJ levels_NNS during_IN the_DT exposure_NN period_NN ,_,
          indicating_VBG that_IN GAG_NNP was_VBD not_RB totally_RB depleted_VBN from_IN the_DT
          disks_NNS at_IN these_DT exposure_NN levels_NNS ._. Turning_NNP to_TO the_DT recovery_NN
          period_NN ,_, within_IN 1_CD -_: 2_CD days_NNS after_IN cessation_NN of_IN IL-_NNP 1_CD exposure_NN
          the_DT GAG_NNP release_NN rates_NNS dropped_VBD to_TO levels_NNS comparable_JJ with_IN
          those_DT of_IN control_NN samples_NNS ._. GAG_NNP release_NN persisted_VBD at_IN this_DT
          level_NN (_( 0_CD ._. 3_LS Â±_NN 0_CD ._. 1_LS and_CC 0_CD ._. 5_CD Â±_NN 0_CD ._. 3_LS Î¼g_NN /_NN mg_NN initial_JJ wet-weight_JJ /_NN day_NN
          for_IN '_POS mild_JJ '_POS and_CC '_POS moderate_JJ '_POS groups_NNS ,_, respectively_RB )_)
          throughout_IN the_DT remainder_NN of_IN the_DT study_NN ._.
        
        
          Tissue_NNP glycosaminoglycan_NN concentration_NN over_IN
          time_NN
          Use_NN of_IN dGEMRIC_NN allowed_VBN for_IN the_DT actual_JJ [_NN GAG_NNP ]_NN in_IN the_DT
          tissue_NN to_TO be_VB followed_VBN over_IN time_NN ._. The_DT images_NNS of_IN the_DT
          control_NN samples_NNS showed_VBD relatively_RB stable_JJ [_NN GAG_NNP ]_NN over_IN the_DT
          culture_NN period_NN (_( Fig_NNP ._. 1_LS a_DT ,_, 1_CD c_SYM )_) ,_, with_IN the_DT coefficient_NN of_IN
          variation_NN (_( SD_NNP /_NN mean_NN over_IN time_NN )_) for_IN '_POS bulk_NN '_'' GAG_NNP (_( i_NNP ._. e_SYM ._. GAG_NNP
          averaged_VBD over_IN the_DT entire_JJ cartilage_NN image_NN slice_NN )_) ranging_VBG
          from_IN 2_CD %_NN to_TO 12_CD %_NN ._. One_PRP can_MD also_RB see_VB that_IN the_DT bulk_NN [_NN GAG_NNP ]_NN was_VBD
          considerably_RB different_JJ for_IN the_NNP '_POS mild_JJ '_POS and_CC '_POS moderate_JJ '_POS
          control_NN samples_NNS ._. This_DT is_VBZ probably_RB a_DT reflection_NN of_IN
          differences_NNS between_IN the_DT animals_NNS used_VBN for_IN each_DT series_NN ,_, a_DT
          conclusion_NN supported_VBN by_IN considering_VBG measurements_NNS made_VBN
          before_IN IL-_NNP 1_CD exposure_NN on_IN a_DT subset_NN of_IN samples_NNS (_( 92_CD Â±_NN 11_CD mg_NN /_NN ml_NN
          for_IN the_NNP '_POS mild_JJ '_POS series_NN and_CC 57_CD Â±_NN 6_CD mg_NN /_NN ml_NN for_IN the_NNP '_POS moderate_JJ '_POS
          series_NN ;_: 
          n_NN =_SYM 6_CD for_IN each_DT )_) ._. To_TO provide_VB a_DT
          relative_JJ reference_NN ,_, the_DT mean_NN and_CC SD_NNP of_IN untreated_JJ samples_NNS
          are_VBP represented_VBN by_IN the_DT shaded_JJ regions_NNS in_IN Fig_NNP ._. 2_LS a_DT ,_, 2_CD b_SYM ._.
          Images_NNP of_IN the_DT exposed_VBN samples_NNS acquired_VBN immediately_RB
          following_VBG cessation_NN of_IN IL-_NNP 1_CD revealed_VBD a_DT much_RB lower_JJR [_NN GAG_NNP ]_NN
          than_IN the_DT initial_JJ values_NNS ,_, and_CC the_DT [_NN GAG_NNP ]_NN in_IN exposed_VBN samples_NNS
          increased_VBN with_IN time_NN of_IN recovery_NN (_( Figs_NNP 1_CD and_CC 2_LS )_) ._. Over_IN the_DT
          3_CD -_: week_NN recovery_NN period_NN following_VBG IL-_NNP 1_CD exposure_NN ,_, [_NN GAG_NNP ]_NN
          increased_VBD in_IN all_DT samples_NNS exposed_VBN to_TO IL-_NNP 1_CD (_( Fig_NNP ._. 1_LS b_SYM ,_, 1_CD dand_NN
          Fig_NNP ._. 2_LS ,_, 
          n_NN =_SYM 14_CD ;_: 
          P_NN <_NN 0_CD ._. 0001_CD )_) ._. In_IN the_NNP '_POS mild_JJ '_POS group_NN
          the_DT [_NN GAG_NNP ]_NN increased_VBD by_IN 19_CD Â±_NN 5_CD mg_NN /_NN ml_NN (_( 
          n_NN =_SYM 4_CD ;_: 
          P_NN =_SYM 0_CD ._. 06_CD )_) whereas_IN in_IN the_NNP '_POS moderate_JJ '_POS
          group_NN [_NN GAG_NNP ]_NN increased_VBD by_IN 26_CD Â±_NN 11_CD mg_NN /_NN ml_NN (_( 
          n_NN =_SYM 10_CD ;_: 
          P_NN <_NN 0_CD ._. 0001_CD )_) ._.
          Given_VBN the_DT variation_NN in_IN initial_JJ [_NN GAG_NNP ]_NN ,_, we_PRP evaluated_VBD the_DT
          percentage_NN degree_NN of_IN recovery_NN only_RB for_IN those_DT samples_NNS for_IN
          which_WDT we_PRP obtained_VBD an_DT '_POS initial_JJ '_POS image_NN before_IN any_DT exposure_NN
          to_TO IL-_NNP 1_CD (_( 
          n_NN =_SYM 4_CD '_POS mild_JJ '_POS and_CC 
          n_NN =_SYM 4_CD '_POS moderate_JJ '_POS )_) ._. In_IN these_DT cases_VBZ
          the_DT [_NN GAG_NNP ]_NN after_IN 3_CD weeks_NNS of_IN recovery_NN did_VBD not_RB reach_VB the_DT
          initial_JJ levels_NNS ._. The_DT [_NN GAG_NNP ]_NN in_IN the_NNP '_POS mild_JJ '_POS group_NN reached_VBD 77_CD
          Â±_NN 19_CD %_NN of_IN initial_JJ [_NN GAG_NNP ]_NN (_( 
          n_NN =_SYM 4_CD ;_: 
          P_NN =_SYM 0_CD ._. 019_CD )_) and_CC the_NNP '_POS moderate_JJ '_POS group_NN
          reached_VBD 49_CD Â±_NN 11_CD %_NN of_IN initial_JJ [_NN GAG_NNP ]_NN (_( 
          n_NN =_SYM 4_CD ;_: 
          P_NN =_SYM 0_CD ._. 00003_CD )_) ._.
        
        
          Regional_JJ analysis_NN of_IN glycosaminoglycan_NN
          concentration_NN recovery_NN
          The_DT mean_JJ rate_NN of_IN [_NN GAG_NNP ]_NN recovery_NN (_( increase_NN in_IN
          [_NN GAG_NNP ]_NN /_NN time_NN )_) averaged_VBD across_IN all_DT pixels_NNS of_IN IL-_NNP 1_CD -_: degraded_JJ
          samples_NNS remained_VBD steady_JJ throughout_IN 3_CD weeks_NNS of_IN
          post-_NN IL-_NNP 1_CD -_: exposure_NN culture_NN at_IN a_DT rate_NN of_IN 1_CD -_: 2_CD mg_NN /_NN ml_NN per_IN day_NN
          (_( 1_CD ._. 2_LS Â±_NN 0_CD ._. 9_CD mg_NN /_NN ml_NN per_IN day_NN )_) ._. However_RB ,_, looking_VBG specifically_RB at_IN
          the_DT spatial_NN distribution_NN of_IN [_NN GAG_NNP ]_NN ,_, considerable_JJ
          differences_NNS in_IN weekly_JJ [_NN GAG_NNP ]_NN recovery_NN are_VBP clearly_RB evident_JJ
          across_IN different_JJ regions_NNS of_IN the_DT same_JJ samples_NNS ._.
          In_IN both_DT the_NNP '_POS mild_JJ '_POS and_CC '_POS moderate_JJ '_POS groups_NNS ,_,
          heterogeneous_JJ degradation_NN patterns_NNS prevailed_VBD ,_, with_IN
          greatest_JJS degradation_NN occurring_VBG in_IN perivascular_NN regions_NNS
          (_( Fig_NNP ._. 1_LS c_SYM ,_, 1_CD d_SYM )_) ,_, although_IN the_DT degradation_NN in_IN the_NNP '_POS moderate_JJ '_POS
          group_NN was_VBD more_RBR severe_JJ and_CC homogeneous_JJ than_IN in_IN the_NNP '_POS mild_JJ '_POS
          group_NN (_( the_DT control_NN images_NNS and_CC abundant_JJ experience_NN with_IN
          this_DT model_NN system_NN supports_VBZ the_DT implicit_JJ assumption_NN here_RB
          that_IN the_DT initial_JJ [_NN before_IN IL-_NNP 1_CD ]_NN distribution_NN of_IN GAG_NNP was_VBD
          homogeneous_JJ )_) ._.
          From_IN a_DT qualitative_JJ examination_NN of_IN the_DT recovery_NN images_NNS ,_,
          it_PRP can_MD also_RB be_VB appreciated_VBN that_IN the_DT regions_NNS with_IN
          relatively_RB low_JJ [_NN GAG_NNP ]_NN after_IN 3_CD weeks_NNS are_VBP also_RB the_DT regions_NNS
          that_WDT had_VBD relatively_RB low_JJ [_NN GAG_NNP ]_NN at_IN the_DT beginning_NN of_IN the_DT
          recovery_NN period_NN ,_, immediately_RB after_IN IL-_NNP 1_CD exposure_NN (_( Figs_NNP
          1_CD and_CC 3_LS )_) ._.
          To_TO examine_VB this_DT observation_NN more_RBR quantitatively_RB and_CC to_TO
          assess_VB whether_IN the_DT rates_NNS of_IN GAG_NNP accumulation_NN were_VBD
          correspondingly_RB heterogeneous_JJ ,_, we_PRP examined_VBD separately_RB the_DT
          [_NN GAG_NNP ]_NN accumulation_NN in_IN three_CD '_POS regions_NNS '_POS ,_, namely_RB those_DT with_IN
          '_POS high_JJ '_POS ,_, '_'' medium_NN '_'' and_CC '_POS low_JJ '_POS [_NN GAG_NNP ]_NN at_IN week_NN 3_CD (_( as_IN specified_VBN
          above_IN ,_, under_IN Image_NN processing_NN )_) ,_, which_WDT is_VBZ illustrated_VBN for_IN
          one_CD sample_NN in_IN Fig_NNP ._. 3_LS a_DT ._. Interestingly_RB ,_, regions_NNS of_IN '_POS low_JJ '_POS
          [_NN GAG_NNP ]_NN appeared_VBD to_TO recover_VB at_IN the_DT same_JJ rate_NN as_IN did_VBD regions_NNS
          of_IN '_POS medium_NN '_'' or_CC '_POS high_JJ '_POS [_NN GAG_NNP ]_NN during_IN the_DT first_JJ 2_CD weeks_NNS of_IN
          post-_NN IL-_NNP 1_CD -_: exposure_NN culture_NN ._. In_IN the_DT first_JJ 2_CD weeks_NNS of_IN
          recovery_NN ,_, all_DT regions_NNS recovered_VBD at_IN a_DT rate_NN of_IN 10_CD -_: 15_CD mg_NN /_NN ml_NN
          per_IN week_NN ._. During_IN the_DT third_JJ week_NN the_DT recovery_NN patterns_NNS for_IN
          the_DT three_CD regions_NNS differed_VBD significantly_RB (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) ,_, with_IN the_NNP '_POS low_JJ '_POS
          regions_NNS showing_VBG negligible_JJ [_NN GAG_NNP ]_NN accumulation_NN and_CC the_NNP
          '_POS high_JJ '_POS regions_NNS the_DT greatest_JJS accumulation_NN (_( Fig_NNP ._.
          3_LS a_DT ,_, 3_CD c_SYM )_) ._.
        
      
      
        Discussion_NNP
        The_DT present_JJ study_NN clearly_RB demonstrates_VBZ that_IN bovine_JJ
        cartilage_NN explants_NNS can_MD ,_, at_IN least_JJS partially_RB ,_, recover_VB from_IN
        IL-_NNP 1_CD -_: induced_VBN degradation_NN by_IN synthesizing_VBG new_JJ GAG_NNP but_CC that_IN
        the_DT ultimate_JJ rate_NN of_IN recovery_NN may_MD be_VB dependent_JJ on_IN the_DT
        degree_NN of_IN initial_JJ depletion_NN ._. By_IN monitoring_VBG the_DT spatially_RB
        localized_JJ changes_NNS in_IN [_NN GAG_NNP ]_NN over_IN a_DT 3_CD -_: week_NN recovery_NN period_NN ,_,
        we_PRP showed_VBD that_DT [_NN GAG_NNP ]_NN increases_NNS significantly_RB with_IN time_NN in_IN
        post-_NN IL-_NNP 1_CD -_: exposure_NN culture_NN ,_, with_IN the_DT early_JJ recovery_NN (_( first_JJ
        2_CD weeks_NNS )_) being_VBG independent_JJ of_IN absolute_JJ [_NN GAG_NNP ]_NN but_CC the_DT later_JJ
        recovery_NN (_( third_JJ week_NN )_) occurring_VBG only_RB in_IN regions_NNS with_IN higher_JJR
        [_NN GAG_NNP ]_NN ._.
        With_IN respect_NN to_TO the_DT spatial_NN heterogeneity_NN in_IN recovery_NN
        rates_NNS ,_, we_PRP are_VBP not_RB aware_JJ of_IN any_DT histologic_JJ (_( or_CC other_JJ )_) data_NNS
        describing_VBG the_DT apparent_JJ dependence_NN of_IN the_DT rate_NN of_IN [_NN GAG_NNP ]_NN
        replenishment_NN on_IN the_DT initial_JJ state_NN of_IN the_DT ECM_NNP ._. We_PRP
        previously_RB showed_VBD that_IN spontaneous_JJ recovery_NN from_IN complete_JJ
        trypsin-induced_JJ GAG_NNP loss_NN occurs_VBZ uniformly_RB throughout_IN the_DT
        tissue_NN ,_, showing_VBG no_DT significant_JJ spatial_NN heterogeneity_NN in_IN
        recovery_NN rates_NNS and_CC nearly_RB complete_JJ recovery_NN to_TO the_DT initial_JJ
        state_NN in_IN approximately_RB 5_CD weeks_NNS [_NN 14_CD ]_NN ._. Those_DT data_NNS suggest_VBP
        that_IN the_DT capacity_NN for_IN cells_NNS to_TO synthesize_VB new_JJ matrix_NN is_VBZ
        uniform_NN throughout_IN the_DT tissue_NN ._. Thus_RB ,_, the_DT differential_NN
        response_NN seen_VBN here_RB is_VBZ presumably_RB due_JJ to_TO the_DT state_NN of_IN the_DT
        ECM_NNP immediately_RB after_IN IL-_NNP 1_CD exposure_NN ._.
        Here_RB ,_, we_PRP consider_VBP [_NN GAG_NNP ]_NN as_IN a_DT surrogate_NN for_IN defining_VBG the_DT
        ECM_NNP state_NN immediately_RB following_VBG IL-_NNP 1_CD exposure_NN ._. [_NN GAG_NNP ]_NN itself_PRP
        is_VBZ one_CD direct_JJ measure_NN of_IN ECM_NNP state_NN ._. In_IN the_DT context_NN of_IN the_DT
        present_JJ study_NN ,_, [_NN GAG_NNP ]_NN might_MD also_RB serve_VB as_IN a_DT surrogate_NN for_IN
        the_DT state_NN of_IN other_JJ ECM_NNP macromolecules_NNS ,_, such_JJ as_IN collagen_NN ._.
        Given_VBN the_DT broad_JJ spectrum_NN of_IN IL-_NNP 1_CD -_: induced_VBN enzymes_NNS ,_, we_PRP
        consider_VBP that_IN regions_NNS of_IN the_DT tissue_NN where_WRB [_NN GAG_NNP ]_NN is_VBZ more_RBR
        severely_RB affected_VBN by_IN IL-_NNP 1_CD may_MD also_RB be_VB regions_NNS that_WDT
        experience_NN greater_JJR damage_NN to_TO the_DT collagen_NN network_NN ,_, as_IN
        compared_VBN with_IN regions_NNS that_WDT are_VBP more_RBR resistant_JJ to_TO the_DT
        effects_NNS of_IN IL-_NNP 1_CD ._. Our_PRP$ finding_VBG that_IN the_DT regions_NNS that_WDT
        experienced_VBD the_DT least_JJS recovery_NN were_VBD those_DT most_RBS severely_RB
        affected_VBN by_IN IL-_NNP 1_CD could_MD be_VB a_DT consequence_NN of_IN these_DT same_JJ
        regions_NNS sustaining_VBG more_RBR significant_JJ damage_NN to_TO the_DT ECM_NNP
        network_NN ._. This_DT conclusion_NN is_VBZ consistent_JJ with_IN findings_NNS
        regarding_VBG IL-_NNP 1_CD -_: induced_VBN degradation_NN in_IN rabbits_NNS ,_, in_IN which_WDT
        recovery_NN rates_NNS decreased_VBD with_IN apparent_JJ severity_NN of_IN
        degradation_NN [_NN 1_CD ]_NN ._.
        Interestingly_RB ,_, it_PRP is_VBZ in_IN the_DT latter_JJ phase_NN of_IN recovery_NN
        that_IN a_DT discrepancy_NN in_IN recovery_NN rates_NNS becomes_VBZ evident_JJ ._.
        During_IN the_DT early_JJ phases_NNS of_IN recovery_NN ,_, the_DT rate_NN of_IN [_NN GAG_NNP ]_NN
        accumulation_NN in_IN the_DT regions_NNS with_IN the_DT lowest_JJS [_NN GAG_NNP ]_NN was_VBD
        comparable_JJ to_TO the_DT rates_NNS of_IN recovery_NN in_IN regions_NNS with_IN the_DT
        highest_JJS [_NN GAG_NNP ]_NN ._. The_DT mechanism_NN for_IN this_DT heterogeneity_NN is_VBZ
        unclear_JJ ._. It_PRP could_MD be_VB a_DT manifestation_NN of_IN a_DT corresponding_JJ
        distribution_NN of_IN IL-_NNP 1_CD -_: induced_VBN changes_NNS in_IN chondrocyte_NN
        metabolism_NN or_CC viability_NN [_NN 23_CD ]_NN ,_, or_CC it_PRP could_MD be_VB a_DT
        manifestation_NN of_IN a_DT corresponding_JJ distribution_NN of_IN damage_NN to_TO
        the_DT collagen_NN scaffold_NN ,_, which_WDT in_IN turn_NN limits_NNS the_DT ability_NN to_TO
        replenish_VB [_NN GAG_NNP ]_NN ._. Kruijsen_NNP 
        et_CC al_NN ._. [_NN 24_CD ]_NN showed_VBD that_IN both_DT the_DT
        severity_NN and_CC chronicity_NN of_IN antigen-induced_JJ inflammation_NN
        determined_VBD the_DT degree_NN of_IN chondrocyte_NN killing_VBG in_IN their_PRP$ 
        in_IN vivo_NN murine_NN model_NN of_IN arthritis_NN ._.
        Their_PRP$ studies_NNS showed_VBD that_DT chondrocyte_NN death_NN was_VBD most_RBS highly_RB
        correlated_JJ with_IN the_DT degree_NN of_IN joint_JJ inflammation_NN present_JJ 14_CD
        days_NNS after_IN arthritis_NN induction_NN ._. That_DT finding_VBG suggests_VBZ that_WDT
        sustained_VBD exposure_NN to_TO IL-_NNP 1_CD ,_, a_DT proinflammatory_NN agent_NN ,_, may_MD
        also_RB cause_VB chondrocyte_NN death_NN ._. However_RB ,_, the_DT fact_NN that_IN the_DT
        early_JJ recovery_NN phase_NN in_IN the_DT present_JJ study_NN showed_VBD no_DT
        heterogeneity_NN makes_VBZ cell_NN death_NN a_DT less_RBR likely_JJ cause_NN of_IN
        limited_JJ [_NN GAG_NNP ]_NN replenishment_NN ._.
        A_DT limitation_NN (_( and_CC obvious_JJ next_JJ step_NN )_) to_TO this_DT study_NN is_VBZ
        that_IN we_PRP do_VBP not_RB have_VB independent_JJ information_NN about_IN the_DT
        integrity_NN of_IN the_DT collagen_NN matrix_NN ._. Magnetic_JJ resonance_NN
        imaging_NN techniques_NNS are_VBP actively_RB being_VBG developed_VBN to_TO image_NN
        the_DT collagen_NN component_NN of_IN tissue_NN ,_, which_WDT can_MD be_VB incorporated_VBN
        into_IN future_JJ studies_NNS [_NN 25_CD ]_NN ._. Human_NNP osteoarthritic_JJ tissue_NN
        is_VBZ ,_, by_IN histologic_JJ measures_NNS ,_, spatially_RB heterogeneous_JJ in_IN both_DT
        collagen_NN damage_NN and_CC degree_NN of_IN proteoglycan_NN depletion_NN ._. The_DT
        notion_NN that_IN the_DT differential_NN ability_NN to_TO replenish_VB GAG_NNP fully_RB
        is_VBZ related_VBN to_TO the_DT differential_NN state_NN of_IN the_DT collagen_NN matrix_NN
        has_VBZ been_VBN suggested_VBN by_IN others_NNS ,_, based_VBN in_IN part_NN on_IN the_DT finding_VBG
        that_IN GAG_NNP depletion_NN corresponds_NNS with_IN regions_NNS that_WDT are_VBP
        positive_JJ for_IN the_DT col_NN 3_CD /_NN 4_CD epitope_NN ,_, which_WDT is_VBZ indicative_JJ of_IN
        collagen_NN damage_NN [_NN 6_CD 26_CD ]_NN ._. Although_IN we_PRP lack_VBP specific_JJ
        information_NN on_IN the_DT state_NN of_IN the_DT collagen_NN matrix_NN ,_, the_DT
        differences_NNS observed_VBD in_IN the_DT present_JJ study_NN (_( and_CC ,_, indeed_RB ,_, the_DT
        demonstrated_VBN ability_NN to_TO evaluate_VB regional_JJ differences_NNS in_IN
        response_NN )_) suggest_VBP that_DT dGEMRIC_NN and_CC model_NN systems_NNS such_JJ as_IN
        these_DT may_MD be_VB useful_JJ for_IN establishing_VBG a_DT better_JJR understanding_NN
        of_IN the_DT capacity_NN of_IN cartilage_NN to_TO repair_VB osteoarthritis-like_JJ
        degradation_NN ._.
        The_DT rate_NN of_IN GAG_NNP replenishment_NN observed_VBD in_IN this_DT study_NN
        compares_VBZ well_RB with_IN published_VBN synthesis_NN data_NNS ._. Using_VBG sulfate_NN
        incorporation_NN over_IN periods_NNS of_IN less_JJR than_IN 24_CD hours_NNS ,_, we_PRP and_CC
        others_NNS have_VBP reported_VBN sulfate_NN incorporation_NN ratios_NNS between_IN
        0_CD ._. 06_CD and_CC 0_CD ._. 13_CD nmol_NN /_NN mg_NN wet-weight_JJ /_NN hour_NN for_IN young_JJ bovine_JJ
        cartilage_NN [_NN 27_CD 28_CD 29_CD ]_NN ._. These_DT incorporation_NN rates_NNS imply_VBP
        GAG_NNP synthesis_NN rates_NNS of_IN 6_CD -_: 13_CD mg_NN /_NN ml_NN tissue_NN water_NN per_IN week_NN
        (_( assuming_VBG 1_CD sulfate_NN per_IN disaccharide_NN ,_, 502_CD g_SYM /_NN mol_NN
        disaccaride_NN ,_, and_CC 0_CD ._. 8_CD ml_NN tissue_NN water_NN /_NN g_SYM wet-weight_JJ )_) ._. By_IN
        comparison_NN ,_, we_PRP observed_VBD GAG_NNP accumulation_NN rates_NNS of_IN 4_CD -_: 14_CD mg_NN /_NN ml_NN
        per_IN week_NN ,_, as_IN inferred_VBN from_IN the_DT change_NN in_IN [_NN GAG_NNP ]_NN ._. These_DT
        values_NNS also_RB compare_VBP well_RB with_IN the_DT 2_CD -_: 7_CD ._. 3_LS mg_NN /_NN ml_NN per_IN week_NN rates_NNS
        of_IN GAG_NNP replenishment_NN seen_VBN in_IN young_JJ bovine_JJ cartilage_NN
        explants_NNS recovering_VBG from_IN trypsin-induced_JJ GAG_NNP depletion_NN [_NN 14_CD
        ]_NN ._. Comparison_NNP of_IN these_DT GAG_NNP accumulation_NN rates_NNS with_IN the_DT
        rate_NN of_IN GAG_NNP release_NN into_IN the_DT culture_NN medium_NN clearly_RB
        suggests_VBZ that_IN at_IN least_JJS 75_CD %_NN of_IN the_DT newly_RB synthesized_JJ GAG_NNP is_VBZ
        retained_VBN by_IN the_DT tissue_NN ._. (_( By_IN contrast_NN ,_, in_IN control_NN tissue_NN the_DT
        amount_NN of_IN GAG_NNP synthesized_JJ is_VBZ roughly_RB equivalent_JJ to_TO the_DT
        amount_NN released_VBN into_IN the_DT medium_NN ._. )_)
        We_PRP do_VBP not_RB have_VB the_DT ability_NN to_TO determine_VB the_DT regional_JJ
        variations_NNS in_IN synthesis_NN and_CC loss_NN ._. Although_IN we_PRP clearly_RB
        observed_VBD regional_JJ variations_NNS in_IN [_NN GAG_NNP ]_NN accumulation_NN ,_, it_PRP is_VBZ
        important_JJ to_TO appreciate_VB that_IN these_DT differences_NNS could_MD arise_VB
        by_IN regional_JJ differences_NNS in_IN synthesis_NN or_CC in_IN loss_NN ,_, or_CC
        both_DT ._.
        Looking_VBG more_RBR generally_RB at_IN attempts_NNS to_TO evaluate_VB [_NN GAG_NNP ]_NN
        recovery_NN in_IN IL-_NNP 1_CD -_: degraded_JJ cartilage_NN ,_, our_PRP$ data_NNS are_VBP
        consistent_JJ with_IN the_DT temporal_JJ progression_NN seen_VBN in_IN other_JJ
        model_NN systems_NNS in_IN which_WDT recovery_NN occurs_VBZ and_CC is_VBZ measurable_JJ
        within_IN the_DT first_JJ few_JJ weeks_NNS after_IN a_DT [_NN GAG_NNP ]_NN -_: depleting_VBG
        intervention_NN ._. For_IN example_NN ,_, Takegami_NNP 
        et_CC al_NN ._. [_NN 9_CD ]_NN reported_VBD [_NN GAG_NNP ]_NN recovery_NN
        in_IN alginate_NN cultures_NNS of_IN human_JJ intervertebral_NN disc_NN cells_NNS
        pre-exposed_JJ to_TO 0_CD ._. 5_CD ng_NN /_NN ml_NN IL-_NNP 1_CD for_IN 3_CD days_NNS ._. During_IN the_DT first_JJ 2_CD
        weeks_NNS of_IN post-_NN IL-_NNP 1_CD -_: exposure_NN culture_NN ,_, those_DT investigators_NNS
        observed_VBD [_NN GAG_NNP ]_NN recovery_NN rates_NNS of_IN approximately_RB 4_CD %_NN /_NN day_NN with_IN
        very_RB little_JJ change_NN in_IN [_NN GAG_NNP ]_NN observed_VBD during_IN the_DT third_JJ week_NN ,_,
        when_WRB [_NN GAG_NNP ]_NN levels_NNS reached_VBN about_IN 85_CD %_NN of_IN the_DT control_NN level_NN ._.
        In_IN an_DT 
        in_IN vivo_NN rabbit_NN knee_NN joint_JJ subjected_VBN
        to_TO intra-articular_JJ injections_NNS of_IN IL-_NNP 1_CD ,_, Page_NNP Thomas_NNP 
        et_CC al_NN ._. [_NN 3_CD ]_NN used_VBD SO_NNP 
        4_CD uptake_NN and_CC toluidine_NN blue_JJ staining_VBG to_TO
        observe_VB GAG_NNP losses_NNS of_IN 25_CD -_: 60_CD %_NN in_IN several_JJ cartilage_NN sites_NNS
        within_IN the_DT knee_NN ,_, with_IN gradual_JJ recovery_NN over_IN the_DT subsequent_JJ
        3_CD -_: 4_CD weeks_NNS ._. Arner_NNP [_NN 1_CD ]_NN also_RB examined_VBD 
        in_IN vivo_NN GAG_NNP synthesis_NN and_CC
        accumulation_NN in_IN rabbits_NNS following_VBG intra-articular_JJ
        injections_NNS of_IN IL-_NNP 1_CD ._. Using_VBG dimethylmethylene_NN blue_JJ assay_NN and_CC
        sulfate_NN incorporation_NN ,_, Arner_NNP found_VBD that_IN both_DT single_JJ and_CC
        multiple_JJ injections_NNS of_IN IL-_NNP 1_CD led_VBN to_TO an_DT initial_JJ depression_NN in_IN
        GAG_NNP synthesis_NN rate_NN and_CC a_DT slight_JJ drop_NN in_IN tissue_NN [_NN GAG_NNP ]_NN for_IN 4_CD
        days_NNS after_IN IL-_NNP 1_CD exposure_NN ._. These_DT changes_NNS were_VBD followed_VBN by_IN
        enhanced_JJ synthesis_NN (_( relative_JJ to_TO controls_NNS )_) ,_, with_IN a_DT
        commensurate_JJ increase_NN in_IN tissue_NN [_NN GAG_NNP ]_NN over_IN the_DT subsequent_JJ 2_CD
        weeks_NNS as_IN the_DT content_NN of_IN GAG_NNP in_IN the_DT tissue_NN approached_VBD 90_CD %_NN of_IN
        control_NN levels_NNS ._. In_IN those_DT 
        in_IN vivo_NN systems_NNS it_PRP appears_VBZ that_IN GAG_NNP
        loss_NN continues_VBZ for_IN 4_CD -_: 7_CD days_NNS after_IN IL-_NNP 1_CD exposure_NN [_NN 1_CD ]_NN ._.
        This_DT is_VBZ longer_RBR than_IN the_DT 1_CD -_: 2_CD days_NNS seen_VBN in_IN the_DT present_JJ study_NN
        (_( in_IN which_WDT GAG_NNP loss_NN into_IN the_DT medium_NN returned_VBD to_TO control_VB
        levels_NNS )_) ,_, and_CC is_VBZ probably_RB a_DT consequence_NN of_IN IL-_NNP 1_CD clearing_VBG
        more_RBR quickly_RB from_IN the_DT 
        in_IN vitro_NN environment_NN ._.
        Thus_RB ,_, in_IN widely_RB different_JJ model_NN systems_NNS -_: including_VBG that_WDT
        reported_VBD here_RB -_: it_PRP appears_VBZ that_IN after_IN an_DT IL-_NNP 1_CD -_: induced_VBN
        GAG-depleting_NNP intervention_NN tissue_NN can_MD reaccumulate_NN GAG_NNP and_CC
        does_VBZ so_RB most_RBS rapidly_RB during_IN the_DT first_JJ few_JJ weeks_NNS ._. However_RB ,_,
        unlike_IN the_DT study_NN described_VBD here_RB ,_, in_IN which_WDT both_DT spatial_NN and_CC
        temporal_JJ changes_NNS in_IN [_NN GAG_NNP ]_NN were_VBD monitored_VBN ,_, in_IN the_DT studies_NNS
        described_VBD above_IN it_PRP was_VBD not_RB possible_JJ to_TO derive_VB more_RBR specific_JJ
        spatial_NN information_NN because_IN the_DT destructive_JJ nature_NN of_IN the_DT
        [_NN GAG_NNP ]_NN measurements_NNS required_VBN that_DT time_NN course_NN information_NN be_VB
        inferred_VBN from_IN averages_NNS of_IN separate_JJ animals_NNS /_NN samples_NNS
        harvested_VBN at_IN different_JJ time_NN points_NNS ._.
        Our_PRP$ data_NNS can_MD also_RB be_VB compared_VBN with_IN those_DT from_IN other_JJ
        studies_NNS in_IN which_WDT magnetic_JJ resonance_NN methods_NNS were_VBD used_VBN to_TO
        monitor_VB changes_NNS in_IN cartilage_NN tissue_NN during_IN culture_NN ._. Our_PRP$
        group_NN previously_RB observed_VBD spatially_RB uniform_NN recovery_NN of_IN
        explants_NNS following_VBG trypsin-induced_JJ GAG_NNP depletion_NN using_VBG
        dGEMRIC_NN ,_, with_IN the_DT increases_NNS in_IN [_NN GAG_NNP ]_NN occurring_VBG most_RBS rapidly_RB
        during_IN the_DT first_JJ week_NN and_CC slowing_VBG considerably_RB after_IN 3_CD
        weeks_NNS [_NN 14_CD ]_NN ._. Williams_NNP 
        et_CC al_NN ._. [_NN 15_CD ]_NN used_VBD the_DT same_JJ method_NN
        to_TO monitor_VB GAG_NNP accumulation_NN in_IN tissue_NN engineered_VBN cartilage_NN
        over_IN 6_CD weeks_NNS ,_, and_CC observed_VBD relatively_RB steady_JJ GAG_NNP
        accumulation_NN over_IN the_DT entire_JJ period_NN ,_, with_IN the_DT bulk_NN of_IN the_DT
        accumulation_NN occurring_VBG at_IN the_DT periphery_NN of_IN the_DT explant_NN ._. The_DT
        initial_JJ state_NN of_IN the_DT cell_NN /_NN polymer_NN construct_VB was_VBD presumably_RB
        uniform_NN ,_, and_CC the_DT heterogeneous_JJ [_NN GAG_NNP ]_NN accumulation_NN was_VBD
        attributed_VBN to_TO differences_NNS in_IN the_DT biophysical_JJ environment_NN ._.
        Potter_NNP 
        et_CC al_NN ._. [_NN 30_CD ]_NN observed_VBD the_DT growth_NN of_IN
        tissue_NN engineered_VBN over_IN a_DT period_NN of_IN 4_CD weeks_NNS using_VBG proton_NN NMR_NNP
        without_IN any_DT additional_JJ contrast_NN agent_NN ._. The_DT relative_JJ changes_NNS
        in_IN T_NN 1_CD and_CC T_NN 2_CD times_NNS of_IN those_DT studies_NNS tracked_VBD the_DT histologic_JJ
        finding_NN that_IN GAG_NNP increased_VBD for_IN the_DT first_JJ 3_CD weeks_NNS and_CC then_RB
        remained_VBD relatively_RB constant_JJ ._. Collectively_RB ,_, those_DT studies_NNS
        and_CC the_DT present_JJ one_CD illustrate_VBP spatial_NN and_CC temporal_JJ
        variations_NNS in_IN GAG_NNP accumulation_NN in_IN native_JJ ,_, treated_VBN ,_, and_CC
        tissue_NN engineered_VBN cartilage_NN ._. Much_JJ work_NN ,_, of_IN course_NN ,_, remains_VBZ
        if_IN we_PRP are_VBP to_TO begin_VB to_TO understand_VB the_DT biochemical_JJ ,_,
        biophysical_JJ ,_, and_CC structural_JJ factors_NNS that_WDT underlie_VB the_DT
        differential_NN behavior_NN ._. Furthermore_RB ,_, much_JJ work_NN remains_VBZ to_TO
        determine_VB the_DT generalizability_NN of_IN the_DT behavior_NN in_IN these_DT
        model_NN systems_NNS involving_VBG young_JJ tissue_NN to_TO behavior_NN of_IN
        cartilage_NN 
        in_IN vivo_NN in_IN older_JJR humans_NNS ._.
      
      
        Conclusion_NNP
        In_IN the_DT present_JJ study_NN we_PRP demonstrated_VBD that_IN chondrocytes_NNS ,_,
        in_IN a_DT matrix_NN degraded_JJ by_IN IL-_NNP 1_CD exposure_NN ,_, partially_RB
        replenished_VBN the_DT GAG_NNP ,_, and_CC the_DT most_RBS severely_RB degraded_JJ regions_NNS
        replenished_VBN less_RBR fully_RB than_IN did_VBD other_JJ regions_NNS ._. Future_JJ
        studies_NNS are_VBP underway_NN to_TO examine_VB whether_IN heterogeneity_NN in_IN
        replenishment_NN rate_NN is_VBZ seen_VBN in_IN human_JJ osteoarthritic_JJ tissue_NN ._.
        The_DT study_NN provides_VBZ additional_JJ evidence_NN that_IN the_DT 
        in_IN vitro_NN dGEMRIC_NN method_NN is_VBZ a_DT
        practical_JJ means_NNS for_IN studying_VBG GAG_NNP homeostasis_NNS and_CC events_NNS
        that_WDT disturb_VB it_PRP ._. Ultimately_RB ,_, such_JJ studies_NNS provide_VBP the_DT
        foundation_NN for_IN evaluating_VBG the_DT effects_NNS of_IN therapeutic_JJ
        interventions_NNS on_IN [_NN GAG_NNP ]_NN degradation_NN or_CC regeneration_NN 
        in_IN vitro_NN or_CC 
        in_IN vivo_NN [_NN 13_CD ]_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        dGEMRIC_NN =_SYM delayed_VBN gadolinium_NN enhanced_VBD magnetic_JJ resonance_NN
        imaging_NN of_IN cartilage_NN ;_: ECM_NNP =_SYM extracellular_NN matrix_NN ;_: GAG_NNP =_SYM
        glycosaminoglycan_NN ;_: IL_NNP =_SYM interleukin_NN ;_: NMR_NNP =_SYM nuclear_JJ magnetic_JJ
        resonance_NN ._.
      
    
  
